Illumina | ILMN - Operating Expenses

Stock Price
127.88
Daily Change
2.44 1.95%
Monthly
1.33%
Yearly
65.33%
Q2 Forecast
125.14

Illumina reported $903M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.44B 27M Dec/2025
Bio Techne USD 241.42M 2.52M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Boston Scientific USD 4.04B 18M Dec/2025
Bruker USD 900.9M 124.3M Dec/2025
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Danaher USD 52.95B 47.61B Mar/2026
Dentsply International USD 423M 1.06B Dec/2025
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Illumina USD 903M 69M Dec/2025
Intuitive Surgical USD 1.91B 89.8M Mar/2026
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Laboratory Of America USD 3.13B 32.4M Dec/2025
Mettler Toledo International USD 777.8M 42.3M Dec/2025
Myriad Genetics USD 212.8M 16.2M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quest Diagnostics USD 2.5B 76M Mar/2026
Quidel USD 760.9M 1.28B Dec/2025
Repligen USD 177.94M 1.82M Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Standard Biotools USD 45.72M 2.7M Dec/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Waters USD 661.85M 1.67B Dec/2025